3-(4-Methoxy-phenyl)-4,5-dihydro-isoxazole-5-carboxylic acid, 95.0%, 2g

Methyl7-fluoro-1H-indazole-5-carboxylate, 98%, 1g

tert-butyl (2S)-2-[4-(3-bromophenyl)-1H-imidazol-2-yl]pyrrolidine-1-carboxylate, 95%, 100mg

1,2-Cyclohexanediamine (cis- and trans- mixture)>98.0%(GC)500mL

Ethyl (S)-azetidine-2-carboxylate, 95+%, 250mg

Methyl 5-oxotetrahydrofuran-2-carboxylate, 95+%, 1g

2-Chloro-5-iodobenzotrifluoride>98.0%(GC)5g

RuCl[(S,S)-Tsdpen](p-cymene)>90%(HPLC)200mg

NN-Diethyl-4-methyl-1-piperazinecarboxamide, 95.0%, 1g

1-isonicotinoyl-4-piperidinone hydrochloride, 95.0%, 5g

1-(4'-Methyl-biphenyl-4-yl)-ethanone, 95.0%, 100mg

(5-Methoxy-1H-indol-3-yl)methanamine, 95.0%, 100mg

4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)morpholine, 95.0%, 100mg